
NYSE:EL
This summary was created by AI, based on 1 opinions in the last 12 months.
Estée Lauder (symbol: EL-N) has garnered significant attention from experts, particularly following a notable performance increase of 68% as of June 10, 2025. This surge is attributed to a combination of solid technical indicators and robust company fundamentals, aligning with expert assessments that favor the stock as a top pick within a short timeframe. Investors have expressed satisfaction with the substantial returns, but there is a sentiment that the stock may have now reached its peak potential. The inclination among experts is that while the stock experienced significant growth, future gains may be limited, warranting a cautious approach going forward.
It's been heavily shorted, but today's FDA approval of Pfizer gave it a boast. It's a play on cross-border travel (prominent in duty-free airports). No wonder it jumped over 1% today.
Hit fresh highs today Is up nearly 20% this year. She loves their deal with Target.